NOV 08, 2017 6:00 AM PST

How Does the ABIM Choosing Wisely Initiative Affect Diagnostic Laboratory Medicine?

Speaker
  • Proprietor, The Fritsma Factor, Your Interactive Hemostasis Resource
    Biography
      George Fristma manages www.fritsmafactor.com, The Fritsma Factor, Your Interactive Hemostasis Resource, an informational blog supported by Precision BioLogic, Inc, Dartmouth, Nova Scotia and is the education director for BioMedica Diagnostics, Inc., Windsor, Nova Scotia.

      George is a consultant for the Laboratory Medicine Division of the Pathology Department, University of Alabama at Birmingham School of Medicine, where he provides lectures for pathology residents and for hematology and pathology fellows. George is an associate professor for Rutgers University and Michigan State University, where he provides web-based instructions in hematology and hemostasis.

      George provides international seminars and webinars in hemostasis and hematology. George is an author for Rodak's Hematology, 5th edition, 2016, Elsevier; and for Quick Guide to Blood Collection, 2nd Edition, 2016, Statistics and Quality Control, 2012; and Quick Guide to Renal Disease Testing, 2011. He is a consulting editor for the Clinical Laboratory Science journal. George holds a bachelor's in biology and chemistry from Calvin College, Grand Rapids, Michigan, a Masters in Medical Technology from Wayne State University, Detroit, and advanced course work from Illinois State University and the University of Illinois at Chicago.

    Abstract

    In 2012, Consumers Reports and the American Board of Internal Medicine Foundation launched the Choosing Wisely campaign. This initiative, which attracts media attention, assists physicians, nurses, pharmacists, and medical laboratory scientists identify overused diagnostic tests and treatments. Over 70 medical specialty societies now collaborate with CR and ABIM to generate diagnostic and treatment guidelines. These include the American Association for Clinical Laboratory Science, the American Association of Blood Banks, the American Society for Hematology, and the American Society for Clinical Pathology, who focus on laboratory test utilization and the blood product administration, CR and ABIM, with support from the Robert Wood Johnson Foundation, support local "Champtions" who develop means for applying Choosing Wisely recommendations. We examine the effects of Choosing Wisely on medical laboratory test ordering and interpretation. 


    Show Resources
    You May Also Like
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    MAR 03, 2020 9:00 AM JST
    C.E. CREDITS
    MAR 03, 2020 9:00 AM JST
    DATE: March 3, 2020 TIME: 9:00am JST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid differentiation of HSPCs at the e...
    FEB 25, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 25, 2020 9:00 AM PST
    Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...
    DEC 10, 2019 9:00 AM PST
    C.E. CREDITS
    DEC 10, 2019 9:00 AM PST
    DATE: December 10, 2019TIME: 9:00am PST, 12:00pm EST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid dif...
    JUN 23, 2020 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 23, 2020 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
    Loading Comments...
    Show Resources